Short-acting β(2)-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

BACKGROUND: To gain a global perspective on short-acting β(2)-agonist (SABA) prescriptions and associated asthma-related clinical outcomes in patients with asthma, we assessed primary health data across 24 countries in five continents. METHODS: SABINA III was a cross-sectional study that employed el...

Descripción completa

Detalles Bibliográficos
Autores principales: Bateman, Eric D., Price, David B., Wang, Hao-Chien, Khattab, Adel, Schonffeldt, Patricia, Catanzariti, Angelina, van der Valk, Ralf J.P., Beekman, Maarten J.H.I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068976/
https://www.ncbi.nlm.nih.gov/pubmed/34561293
http://dx.doi.org/10.1183/13993003.01402-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068976/
https://www.ncbi.nlm.nih.gov/pubmed/34561293
http://dx.doi.org/10.1183/13993003.01402-2021

Ejemplares similares